BioBuzz has partnered with Wilson Sonsini Goodrich & Rosati for the second installment of the #CEOTalks event series. This event will bring you insights from local company executives on the game-changing technologies they are bringing to market to address one of the greatest public health threats of our age; multi-drug resistant bacteria and other infectious agents. However, bringing [….]
“In Conversation” with Mina Izadjoo, President of IPS In preparation for the upcoming CEO Talks Panel on Innovators Combating Drug Resistance, BioBuzz Contributor, Sarah Ellinwood, Ph.D. caught up with one of the panelists, President and CSO of Integrated Pharma Services (IPS), Dr. Mina Izadjoo for a preliminary “In Conversation” interview. What is your background and [….]
Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance For Dr. Carol Nacy, co-founder and CEO of Rockville, Maryland’s clinical-stage antibiotics developer Sequella, it all started with a fascination for things unseen. “At Catholic University a few wonderful biology professors introduced me to this amazing world of invisible life that [….]
